Showing results (1661-1670 of 4,166) with videos related to

Sort By:
Pageof 417
Translational Cancer Research|February 12, 2026
Therapeutic application of IL-12 for cancer therapyZhiqing Qi, John Maher
Translational Cancer Research|February 12, 2026
Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancersPei Chen, Lu Xiao, Chaoxiang Lv, et al.
Translational Cancer Research|February 12, 2026
CREM regulates the tumor immune microenvironment and predicts prognosis in thyroid carcinomaHao Ling, Guangmei Wu, Long Tang, et al.
Translational Cancer Research|February 12, 2026
The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activationDaofei Ji, Jicheng Li, Peng Wang, et al.
Translational Cancer Research|February 12, 2026
Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot studyElihu Igbinadolor, Tyler J Kristoff, Dong M Shin, et al.
Translational Cancer Research|February 12, 2026
Prognostic value of palmitoylation-regulated mechanisms in glioblastoma: integrated multi-omics analysis via least absolute shrinkage and selection operator (LASSO) regression and single-cell sequencingYujie Ji, Xiangyu Dai, Lei Jiang, et al.
Translational Cancer Research|February 12, 2026
Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2 targeted microbubble-based ultrasound molecular imagingShiyu Zhang, Yuxin Zhang, Dian Tao, et al.
Translational Cancer Research|February 12, 2026
Temporal-spatial evolution of tumor habitat analysis: a bibliometric study on research hotspots and trends in medical imaging (2014-2025)Xuanle Li, Yongde Guo, Shichen Xu, et al.
Translational Cancer Research|February 12, 2026
Tumor microenvironment-guided targeted and immunotherapy in anaplastic thyroid cancer: a literature review from preclinical models to clinical translationHong Kang, Shizhen Wu, Hao Gong, et al.
Translational Cancer Research|February 12, 2026
VDAC1 and VDAC2 as prognostic biomarkers and therapeutic targets in hepatocellular carcinomaYujie Deng, Runmin Long, Meng Tang, et al.
Pageof 417